0001193125-26-330669 – 4 – Amarin Corporation plc

Amarin is a global pharmaceutical company committed to providing cost-effective cardiovascular care to high-risk adult cardiovascular patients. Find out more.

Committed to reducing the cardiovascular disease burden for patients and communities and to advancing the science of cardiovascular care around the world.

Amarin strives to ensure that our stakeholders have access to appropriate information about our financial growth.

Document Details

Form

Filing Date

Aug 3, 2026

Document Date

Aug 1, 2026

Form Description

Statement of changes in beneficial ownership of securities

Filing Group

3,4,5

Company

Amarin Corporation plc

Issuer

AMARIN CORP PLC\UK

Filer

FISHMAN PETER L.

Filing Formats

View HTML

Download PDF

Download DOC

Download XLS

You are about to leave the Amarincorp.com website

You have selected a link that will take you away from the amarincorp.com website. Amarin is not responsible for the content of the alternate website. Privacy and security policies of the alternate website may differ from those practiced by Amarin.

By clicking on the continue button below, you acknowledge the previous statement and will be taken to the linked site. If you want to remain at this site, select the cancel button. Thank you.

Filing Details

Document Details

Filing Formats